These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11219483

  • 1. Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis.
    Gotfried MH, DeAbate CA, Fogarty C, Mathew CP, Sokol WN.
    Clin Ther; 2001 Jan; 23(1):97-107. PubMed ID: 11219483
    [Abstract] [Full Text] [Related]

  • 2. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
    Anzueto A, Niederman MS, Tillotson GS.
    Clin Ther; 1998 Jan; 20(5):885-900. PubMed ID: 9829441
    [Abstract] [Full Text] [Related]

  • 3. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, DeAbate CA, Haverstock D, Aneiro L, Church D.
    Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
    [Abstract] [Full Text] [Related]

  • 4. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
    Wilson R, Schentag JJ, Ball P, Mandell L, 068 Study Group.
    Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
    [Abstract] [Full Text] [Related]

  • 5. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C.
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [Abstract] [Full Text] [Related]

  • 7. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.
    Wilson R, Kubin R, Ballin I, Deppermann KM, Bassaris HP, Leophonte P, Schreurs AJ, Torres A, Sommerauer B.
    J Antimicrob Chemother; 1999 Oct; 44(4):501-13. PubMed ID: 10588312
    [Abstract] [Full Text] [Related]

  • 8. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M, Busman TA, Norris S, Notario GF.
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
    Anzueto A, Fisher CL, Busman T, Olson CA.
    Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
    [Abstract] [Full Text] [Related]

  • 10. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
    Wilson R, Allegra L, Huchon G, Izquierdo JL, Jones P, Schaberg T, Sagnier PP, MOSAIC Study Group.
    Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA, Unowsky J, Zhang H, Townsend L, Talbot GH.
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M, Notario G, Spiller J, Palmer R, Busman T.
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P, Dobryniewska M, Busman T, Notario G.
    Curr Med Res Opin; 2003 Feb; 19(5):411-20. PubMed ID: 13678478
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitis.
    Anzueto A, Gotfried M, Wikler MA, Russo R, Nicholson SC.
    Clin Ther; 2002 Jun; 24(6):906-17. PubMed ID: 12117081
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.
    Sher LD, McAdoo MA, Bettis RB, Turner MA, Li NF, Pierce PF.
    Clin Ther; 2002 Feb; 24(2):269-81. PubMed ID: 11911557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.